Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000503:physiopathology; D004048:Diethylamines; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007192:Indenes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014202:Tremor / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes